Respect Your Univers (RYUN) 0.1894 $RYUN RYU Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Respect Your Univers (RYUN) 0.1894 $RYUN

RYU Announces Closing Date for Arrangement Agreement
ACCESSWIRE - Tue Feb 17, 7:30AM CST
VANCOUVER, BC / ACCESSWIRE / February 17, 2015 Respect Your Universe, Inc. (TSX VENTURE: RYU) (OTCQB:RYUN) ("RYU", a global performance training and fitness brand is pleased to announce that its arrangement agreement (the "Arrangement Agreement" with RYU Apparel Inc., a newly incorporated wholly-owned British Columbia subsidiary of RYU ("RYU Canada", is anticipated to close on February 20, 2015 (the "Effective Date". Pursuant to the Arrangement Agreement, on the Effective Date, all of the shareholders of RYU will be deemed to have exchanged their common shares of RYU (each, a "RYU Share" for common shares of RYU Canada (each, a "RYU Canada Share" on the basis of one RYU Canada Share for each RYU Share held. The RYU Canada Shares are anticipated to be listed on the TSX Venture Exchange on or before February 26, 2015 under the name RYU Apparel Inc., the symbol "RYU", and a CUSIP of 74979J100. RYU has analyzed the benefits and costs to continuing its quotation on the OTCQB in the United States and it has determined that it is in the best interest of the company to cease its quotation on the OTCQB. As such, the RYU Canada Shares are not anticipated to be quoted on the OTCQB following the Effective Date. The RYU Shares are anticipated to be delisted from the TSX Venture Exchange on the Effective Date and cease to be quoted on the OTCQB on the Effective Date.
RYU.VN: 0.170 (+0.020)

RYU Announces Shareholder and Court Approval of Transaction to Change Corporate Jurisdiction
ACCESSWIRE - Wed Feb 04, 7:30AM CST
Vancouver, BC / ACCESSWIRE / February 4, 2015 / Respect Your Universe, Inc. (TSX VENTURE: RYU) (OTCQB:RYUN) ("RYU", a global performance training and fitness brand is pleased to announce that all resolutions presented at RYU's special meeting of shareholders held on January 27, 2015, including the approval of RYU's revised stock option plan, the approval of the stock option grant to Marcello Leone and the approval of the plan of arrangement and share exchange (the "Plan" to change RYU's corporate jurisdiction from the State of Nevada to the Province of British Columbia, were approved by the shareholders of RYU.
RYU.VN: 0.170 (+0.020)

RYU Voted Best New Training Gear for 2015
ACCESSWIRE - Thu Jan 15, 8:00AM CST
Vancouver, BC / ACCESSWIRE / January 15, 2015 / Respect Your Universe, Inc. (TSX VENTURE: RYU) (OTCQB:RYUN) ("RYU", a global performance training and fitness brand is pleased to announce that it has recently been selected as both the "Best" and "Hottest" for 2015 by two of the top fitness and lifestyle media publications in North America.
RYU.VN: 0.170 (+0.020)

RYU Announces Filing of Preliminary 14A
ACCESSWIRE - Fri Nov 21, 3:34PM CST
Vancouver, British Columbia / ACCESSWIRE / November 21, 2014 / Respect Your Universe, Inc. (TSX VENTURE: RYU) (OTCQB:RYUN) ("RYU", a global performance training and fitness brand with origins in the movements and philosophy of martial artistry, created for the multi-discipline athlete, announces that it has filed a preliminary proxy statement on Schedule 14A (the "Schedule 14A" with the Securities and Exchange Commission in connection with a shareholders meeting to approve, among other things, a relocation of its corporate jurisdiction from the State of Nevada to the Province of British Columbia.
RYU.VN: 0.170 (+0.020)

A Letter to Shareholders From The Desk Of The CEO Of Respect Your Universe
PR Newswire - Thu Oct 30, 8:00AM CDT
Respect Your Universe, Inc. (OTCQB:RYUN) (TSX Venture: RYU.V) ("RYU" Five months ago, I was appointed President of RYU and tasked with creating a new regime. At that time RYU had 160,000 units of inventory stagnating on shelves, a high burn rate, inefficient logistics, a long supply chain, a lease in Portland, Oregon that was ill suited for our needs, an under-performing retail store, less than $1 million in annual sales and no positive cash flow.
RYU.VN: 0.170 (+0.020)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 25

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading